Acute reduction of visual acuity and visual field after Pfizer-BioNTech COVID-19 vaccine 2nd dose: a case report

Luca Spiro Santovito; Graziano Pinna

doi:10.1007/s00011-021-01476-9

Acute reduction of visual acuity and visual field after Pfizer-BioNTech COVID-19 vaccine 2nd dose: a case report

Inflamm Res. 2021 Sep;70(9):931-933. doi: 10.1007/s00011-021-01476-9. Epub 2021 Jun 4.

Authors

Luca Spiro Santovito¹, Graziano Pinna²

Affiliations

¹ The Psychiatric Institute, Department of Psychiatry, College of Medicine, University of Illinois at Chicago (UIC), 1601 West Taylor Street, Chicago, IL, 60612, USA.
² The Psychiatric Institute, Department of Psychiatry, College of Medicine, University of Illinois at Chicago (UIC), 1601 West Taylor Street, Chicago, IL, 60612, USA. gpinna@uic.edu.

Abstract

Long-term and rare adverse effects of COVID-19 vaccines are unknown. Hence, it is important to report them to improve the safety profile of the vaccines and enhance their use worldwide. Here, we describe a case of acute visual impairment after Pfizer-BioNTech vaccine second dose.

Publication types

Case Reports
Letter

MeSH terms

COVID-19 Vaccines / adverse effects*
Humans
Male
Middle Aged
Vaccination / adverse effects
Vision Disorders / etiology*
Visual Acuity / drug effects*
Visual Fields*

Substances

COVID-19 Vaccines